William C. Bertrand Jr., Chief Operating Officer: Adaptimmune Therapeutics ADAPY Planned sale · Filed 25/08/29

Trade details

Type: Planned sale notice
Stock: Adaptimmune Therapeutics ADAPY
Person: William C. Bertrand Jr.Chief Operating Officer
Planned sale date: 25/08/28
Filed: 25/08/29

$2,070 to be sold

Adaptimmune Therapeutics trades, last 26 weeks

What else happened in Adaptimmune Therapeutics around then

Filed or reported within 30 days of the trade day · 25/07/29~25/09/27

William C. Bertrand Jr.'s recent trades

William C. Bertrand Jr.COO
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$2,070
207,000 sh
$2,070
Filed 25/08/29
Traded 25/08/28
William C. Bertrand Jr.COO
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$3,239
5,584 sh
$3,239
Filed 25/01/17
Traded 25/01/17
William C. Bertrand Jr.Chief Operating Officer
Planned saleAdaptimmune Therapeutics
Planned sale
Adaptimmune Therapeutics
ADAPY
$3,243
5,584 sh
$3,243
Filed 25/01/17
Traded 25/01/17
William C. Bertrand Jr.COO
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$2,518
4,268 sh
$2,518
Filed 25/01/15
Traded 25/01/13
William C. Bertrand Jr.COO
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$5,588
9,803 sh
$5,588
Filed 25/01/15
Traded 25/01/15

William C. Bertrand Jr., COO — plans to sell 34,500 sh of Adaptimmune Therapeutics ADAPY · $2,070 · around 08/28 | Whalegun